Beryl Drugs Ltd — Board Meeting, 07-08-2025: Board Meeting

Beryl Drugs Limited's Board of Directors has approved the financial results for the quarter ended June 30, 2025. This key update provides investors with a clear view of the company's performance during the period. Additionally, the Board took on record the Limited Review Report from the auditors concerning these financial results, ensuring transparency and accountability for stakeholders. This timely disclosure is crucial for shareholders to assess the company's recent operational health.